SI2606042T1 - Disubstituirane tetrahidrofuranilne spojine kot antagonisti bradikininskega B1-receptorja - Google Patents
Disubstituirane tetrahidrofuranilne spojine kot antagonisti bradikininskega B1-receptorjaInfo
- Publication number
- SI2606042T1 SI2606042T1 SI201130320T SI201130320T SI2606042T1 SI 2606042 T1 SI2606042 T1 SI 2606042T1 SI 201130320 T SI201130320 T SI 201130320T SI 201130320 T SI201130320 T SI 201130320T SI 2606042 T1 SI2606042 T1 SI 2606042T1
- Authority
- SI
- Slovenia
- Prior art keywords
- bradykinin
- receptor antagonists
- disubstituted
- tetrahydrofuranyl compounds
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10173489 | 2010-08-20 | ||
EP11748634.0A EP2606042B1 (de) | 2010-08-20 | 2011-08-19 | Disubstituierte tetrahydofuranyl-verbindungen als antagonisten des bradykinin-b1-rezeptors |
PCT/EP2011/064260 WO2012022795A1 (de) | 2010-08-20 | 2011-08-19 | Disubstituierte tetrahydofuranyl-verbindungen als antagonisten des bradykinin-b1-rezeptors |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2606042T1 true SI2606042T1 (sl) | 2014-12-31 |
Family
ID=44510978
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI201130320T SI2606042T1 (sl) | 2010-08-20 | 2011-08-19 | Disubstituirane tetrahidrofuranilne spojine kot antagonisti bradikininskega B1-receptorja |
Country Status (36)
Country | Link |
---|---|
US (1) | US8937073B2 (sl) |
EP (1) | EP2606042B1 (sl) |
JP (1) | JP5727011B2 (sl) |
KR (1) | KR101822371B1 (sl) |
CN (1) | CN103068817B (sl) |
AP (1) | AP2012006630A0 (sl) |
AR (1) | AR082507A1 (sl) |
AU (1) | AU2011290727B2 (sl) |
BR (1) | BR112013003752A2 (sl) |
CA (1) | CA2807086A1 (sl) |
CL (1) | CL2013000310A1 (sl) |
CO (1) | CO6680689A2 (sl) |
CY (1) | CY1115933T1 (sl) |
DK (1) | DK2606042T3 (sl) |
EA (1) | EA022787B1 (sl) |
EC (1) | ECSP13012495A (sl) |
ES (1) | ES2525296T3 (sl) |
GE (1) | GEP20146196B (sl) |
HK (1) | HK1178902A1 (sl) |
HR (1) | HRP20141172T1 (sl) |
IL (1) | IL224039A (sl) |
MA (1) | MA34578B1 (sl) |
ME (1) | ME01899B (sl) |
MX (1) | MX352548B (sl) |
MY (1) | MY156233A (sl) |
NZ (1) | NZ607435A (sl) |
PE (1) | PE20130810A1 (sl) |
PL (1) | PL2606042T3 (sl) |
PT (1) | PT2606042E (sl) |
RS (1) | RS53622B1 (sl) |
SG (1) | SG187835A1 (sl) |
SI (1) | SI2606042T1 (sl) |
TW (1) | TWI548632B (sl) |
UA (1) | UA108765C2 (sl) |
UY (1) | UY33565A (sl) |
WO (1) | WO2012022795A1 (sl) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102007034620A1 (de) * | 2007-07-25 | 2009-01-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue B1-Antagonisten |
EP2188254B1 (de) | 2007-08-29 | 2012-03-21 | Boehringer Ingelheim International GmbH | Neue bradykinin b1-antagonisten |
US8937073B2 (en) | 2010-08-20 | 2015-01-20 | Boehringer Ingelheim International Gmbh | Disubstituted tetrahydrofuranyl compounds and their use as B1-receptor antagonists |
US10544117B2 (en) | 2014-09-10 | 2020-01-28 | Temple University—Of the Commonwealth System of Higher Education | 5-hydroxytryptamine receptor 7 activity modulators and their method of use |
US20180221365A1 (en) * | 2015-05-12 | 2018-08-09 | Temple University-Of The Commonwealth System Of Higher Education | Novel sigma-2 receptor binders and their method of use |
WO2021198534A1 (en) | 2020-04-04 | 2021-10-07 | Oxurion NV | Plasma kallikrein inhibitors for use in the treatment of coronaviral disease |
US11401303B2 (en) * | 2020-06-15 | 2022-08-02 | Taian City Qihang Biotechnology Co. | Synthetic peptide BRAP and application in preparation of anti-inflammatory drug for COVID-19 thereof |
WO2023148016A1 (en) | 2022-02-04 | 2023-08-10 | Oxurion NV | Biomarker for plasma kallikrein inhibitor therapy response |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI259079B (en) | 2002-02-08 | 2006-08-01 | Merck & Co Inc | N-biphenyl(substituted methyl)aminocycloalkanecarboxamide derivatives |
ATE316954T1 (de) * | 2002-02-08 | 2006-02-15 | Merck & Co Inc | N-biphenylmethylaminocycloalkancarboxamid- derivative |
US7163951B2 (en) | 2002-08-29 | 2007-01-16 | Merck & Co., Inc. | N-biarylmethyl aminocycloalkanecarboxamide derivatives |
CA2534188A1 (en) | 2003-08-07 | 2005-02-24 | Merck & Co., Inc. | Sulfonyl substituted n-(biarylmethyl) aminocyclopropanecarboxamides |
CN1832922A (zh) * | 2003-08-07 | 2006-09-13 | 默克公司 | 磺酰基取代的n-(联芳基甲基)氨基环丙烷甲酰胺类 |
JP2007526311A (ja) * | 2004-03-02 | 2007-09-13 | メルク エンド カムパニー インコーポレーテッド | ブラジキニンアンタゴニストとしてのアミノシクロプロパンカルボキサミド誘導体 |
US20060173023A1 (en) | 2005-02-01 | 2006-08-03 | Wood Michael R | 2-(Bicyclo)alkylamino-derivatives as mediators of chronic pain and inflammation |
WO2008033564A1 (en) * | 2006-09-15 | 2008-03-20 | Hydra Biosciences Inc. | Compounds for modulating trpv3 function |
HUP0600809A3 (en) * | 2006-10-27 | 2008-09-29 | Richter Gedeon Nyrt | New phenylsulfamoyl-benzamide derivatives as bradykinin antagonists, process and intermediates for their preparation and pharmaceutical compositions containing them |
DE102007034620A1 (de) | 2007-07-25 | 2009-01-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue B1-Antagonisten |
EP2025675A1 (de) | 2007-08-14 | 2009-02-18 | Boehringer Ingelheim International GmbH | Arylsulfonamide mit analgetischer Wirkung |
EP2188254B1 (de) | 2007-08-29 | 2012-03-21 | Boehringer Ingelheim International GmbH | Neue bradykinin b1-antagonisten |
AR068509A1 (es) | 2007-09-19 | 2009-11-18 | Jerini Ag | Antagosnistas del receptor de bradiquinina b1 |
WO2010057899A1 (de) | 2008-11-20 | 2010-05-27 | Boehringer Ingelheim International Gmbh | Cykloalkylaminocarbonylderivate als bradykinin-b1-rezeptor antagonisten |
WO2010097374A1 (de) | 2009-02-26 | 2010-09-02 | Boehringer Ingelheim International Gmbh | Verbindungen als bradykinin-b1-antagonisten |
BRPI1008779A2 (pt) | 2009-02-26 | 2020-12-22 | Boehringer Ingelheim International Gmbh. | Compostos como antagonistas de bradiquinina-b1 |
KR101843341B1 (ko) | 2010-02-23 | 2018-03-30 | 베링거 인겔하임 인터내셔날 게엠베하 | 브라디키닌 b1 길항제로서의 화합물 |
JP5934212B2 (ja) | 2010-08-20 | 2016-06-15 | アラーガン、インコーポレイテッドAllergan,Incorporated | 複数のプロスタグランジン受容体に作用し、一般的な抗炎症反応を生じる化合物 |
US8937073B2 (en) | 2010-08-20 | 2015-01-20 | Boehringer Ingelheim International Gmbh | Disubstituted tetrahydrofuranyl compounds and their use as B1-receptor antagonists |
US8901127B2 (en) | 2010-08-20 | 2014-12-02 | Boehringer Ingelheim International Gmbh | Pyridazin derivatives as antagonists of the bradykinin B1 receptor |
US8759537B2 (en) | 2010-08-20 | 2014-06-24 | Boehringer Ingelheim International Gmbh | 3H-imidazo [4, 5-C] pyridine-6-carboxamides as anti-inflammatory agents |
US8586604B2 (en) | 2010-08-20 | 2013-11-19 | Boehringer Ingelheim International Gmbh | Inhibitors of the microsomal prostaglandin E2 synthase-1 |
-
2011
- 2011-08-12 US US13/208,567 patent/US8937073B2/en active Active
- 2011-08-19 MA MA35624A patent/MA34578B1/fr unknown
- 2011-08-19 GE GEAP201113031A patent/GEP20146196B/en unknown
- 2011-08-19 EP EP11748634.0A patent/EP2606042B1/de active Active
- 2011-08-19 AR ARP110103036A patent/AR082507A1/es not_active Application Discontinuation
- 2011-08-19 UY UY0001033565A patent/UY33565A/es not_active Application Discontinuation
- 2011-08-19 SI SI201130320T patent/SI2606042T1/sl unknown
- 2011-08-19 AU AU2011290727A patent/AU2011290727B2/en not_active Ceased
- 2011-08-19 JP JP2013524457A patent/JP5727011B2/ja active Active
- 2011-08-19 KR KR1020137004077A patent/KR101822371B1/ko active IP Right Grant
- 2011-08-19 NZ NZ607435A patent/NZ607435A/en not_active IP Right Cessation
- 2011-08-19 RS RS20140551A patent/RS53622B1/en unknown
- 2011-08-19 ES ES11748634.0T patent/ES2525296T3/es active Active
- 2011-08-19 CA CA2807086A patent/CA2807086A1/en not_active Abandoned
- 2011-08-19 SG SG2013010764A patent/SG187835A1/en unknown
- 2011-08-19 PE PE2013000265A patent/PE20130810A1/es not_active Application Discontinuation
- 2011-08-19 TW TW100129857A patent/TWI548632B/zh active
- 2011-08-19 MX MX2013001965A patent/MX352548B/es active IP Right Grant
- 2011-08-19 PT PT117486340T patent/PT2606042E/pt unknown
- 2011-08-19 CN CN201180039753.8A patent/CN103068817B/zh not_active Expired - Fee Related
- 2011-08-19 DK DK11748634.0T patent/DK2606042T3/da active
- 2011-08-19 PL PL11748634T patent/PL2606042T3/pl unknown
- 2011-08-19 EA EA201201662A patent/EA022787B1/ru not_active IP Right Cessation
- 2011-08-19 UA UAA201303313A patent/UA108765C2/uk unknown
- 2011-08-19 AP AP2012006630A patent/AP2012006630A0/xx unknown
- 2011-08-19 WO PCT/EP2011/064260 patent/WO2012022795A1/de active Application Filing
- 2011-08-19 BR BR112013003752A patent/BR112013003752A2/pt not_active IP Right Cessation
- 2011-08-19 MY MYPI2013000537A patent/MY156233A/en unknown
- 2011-08-19 ME MEP-2014-118A patent/ME01899B/me unknown
-
2012
- 2012-12-31 IL IL224039A patent/IL224039A/en active IP Right Grant
-
2013
- 2013-01-30 CL CL2013000310A patent/CL2013000310A1/es unknown
- 2013-02-28 CO CO13041062A patent/CO6680689A2/es active IP Right Grant
- 2013-03-15 EC ECSP13012495 patent/ECSP13012495A/es unknown
- 2013-06-04 HK HK13106521.0A patent/HK1178902A1/xx not_active IP Right Cessation
-
2014
- 2014-11-26 CY CY20141100985T patent/CY1115933T1/el unknown
- 2014-12-02 HR HRP20141172AT patent/HRP20141172T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20181788T1 (hr) | Supstituirani spojevi piridinon-piridinil | |
AP3391A (en) | 2-Amino-4-arylthiazole compounds as TROA1 antagonists | |
PT2927224T (pt) | Antagonistas de receptores | |
HUE036253T2 (hu) | E-szelektin antagonista vegyületek | |
HRP20150167T1 (en) | Compounds as bradykinin b1 antagonists | |
EP2619204A4 (en) | TRIAZOLOPYRAZINONES AS ANTAGONISTS OF P2X7 RECEPTORS | |
HK1174914A1 (zh) | 受體拮抗劑 | |
PT2606042E (pt) | Compostos de tetra-hidrofuranilo dissubstituídos como antagonistas do receptor b1 de bradicinina | |
HK1175171A1 (en) | Compounds as bradykinin b1 antagonists b1 | |
EP2627329A4 (en) | TRPA1 RECEPTOR ANTAGONIST | |
EP2617717A4 (en) | ANTAGONIST OF P2X4 RECEIVER | |
EP2566494A4 (en) | CXCR4 RECEPTOR COMPOUNDS | |
HK1200443A1 (en) | Compounds as bradykinin b1 antagonists b1 |